I2. Rapid Onset of Pain Relief with Oliceridine (TRV130) vs. Morphine: a Phase 2a/b Study Analysis
David G. Soergel(Novartis (Switzerland)), Franck Skobieranda(Ionis Pharmaceuticals (United States)), Lynn R. Webster(Adherent Technologies (United States)), Eugene R. Viscusi(Thomas Jefferson University), David Burt(Social Science Research Solutions (United States))
Cited by 1
Related Papers
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists
|Regional Anesthesia & Pain Medicine|2018|583
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504